Additional dual agents that target GLP-1 and GIP include Tirzepatide, which has shown to provide greater glycemic control compared to available single agonist agents
This recommendation was developed following 6 cases of non-fatal aspiration in fasted patients taking GLP-1 RAs, and is aimed at reducing the risk of the much-feared pulmonary aspiration seen in unfasted patients with an unprotected airway
A key distinction in the BPC-157 vs TB-500 mechanism profile is that TB-500s anti-inflammatory activity appears particularly effective in cardiac and musculoskeletal tissue, while BPC-157 shows stronger anti-inflammatory effects in gastrointestinal tissue
Diabetes Ther 10 , 16451717 (2019)
CJC 1295 Ipamorelin is a peptide therapy that combines two peptides CJC 1295 and Ipamorelin: CJC 1295 is a growth hormone-releasing hormone (GHRH) Ipamorelin is a growth hormone secretagogue (GHS) Together, they work synergistically to increase the production and release of growth hormone in the body
Lucchini Glutathione Peptide PicoCell Brightening Solution Introducing Lucchini Glutathione Peptide PicoCell Brightening Solution, a groundbreaking skin transformation treatment straight from the heart of Switzerland